Fragments of eDNA representing greater than 99 % of the entire genome of wild-type hepatitis A virus (HAV) strain AGM-27, isolated from an African green monkey, were obtained by the polymerase chain reaction and sequenced. Comparison with other HAV isolates revealed differences in the predicted amino acid sequence in functionally critical parts of the genome. Comparison of the biological properties of r AGM-27 with those of human wild-type and cell culture-adapted HM-175 strains revealed that AGM-27 grew in cell culture significantly better than did wildtype HM-175, but not as well as cell culture-adapted HM-175. AGM-27 and cell culture-adapted HM-175 were distinguishable by their differential growth in CV-I, FRhK-4 and primary AGMK cells.
Introduction
Hepatitis A virus (HAV) has been recovered from several species of New and Old World monkeys, but it is not clear whether these isolates are true simian strains or human strains that have infected primates in captivity. Human strains can produce acute hepatitis in some higher primates, such as the chimpanzee (Dienstag et al., 1975) , marmoset (Saguinus sp.) (Deinhardt et al., 1975) and owl monkey (Aotus trivigatus) (LeDuc et al., 1983) , but only one group has reported that an Old World monkey (stump-tailed monkey, Macaca speciosa) (Mao et al., 1981) developed acute hepatitis after experimental infection. An important question is how different the human and simian isolates actually are.
Recently, comparison of partial genome sequences for two simian strains isolated from an owl monkey (Brown et al., 1989) and a cynomolgus monkey (Macaca fascicularis) revealed that these two simian strains differ greatly from human HAVs in the limited regions examined. Here we report the almost complete sequence of a simian HAV obtained from an African green monkey, and demonstrate extensive differences between the nucleotide sequence of this isolate and those of other simian and human strains. In
The nucleotide sequence data reported have been submitted to the GenBank database and assigned the accession number D00924.
0001-0197 © 1991 SGM addition, we demonstrate that the wild-type simian strain differed from a wild-type human strain in its ability to grow in simian cell cultures.
Methods
HAV. The AGM-27 isolate was obtained as a 10% (w/v) liver homogenate in phosphate-buffered saline (pH 7-2) from a clinically ill African green monkey naturally infected with HAV in a facility for housing primates (Andzhaparidze et al., 1987) .
Primers. Eighty oligonucleotides of 15 nucleotides in length, previously synthesized for sequencing human HAV HM-175 (Cohen et al., 1987a, b) , were used for the polymerase chain reaction (PCR) and sequencing reactions. Forty-eight new primers, between 19 and 24 nucleotides in length and complementary to plus or minus strands of the AGM-27 genome, were synthesized using an Applied Biosystems 391 DNA Synthesizer.
Preparation of virus RNA template for PCR. Liver homogenate (0.5 ml, 10%) from African green monkey 27 (Andzhaparidze et al., 1987) , 20% SDS (to a final concentration of 1%) and 10 mg/ml proteinase K (to a final concentration of I mg/ml) were mixed and incubated for 30 rain at 55 °C. Total nucleic acids were extracted with phenol at 65 °C, precipitated with ethanol and stored in ethanol at -80°C. PCR amplification of the 5' region was very inefficient using RNA purified in this manner and therefore, to increase the yield of PCR fragments from the 5' region, RNA template was extracted from partially purified virions. Liver homogenate (30 ml, 10%) was clarified by centrifugation at 3000 r.p.m, for 1 h at 4 °C in a Beckman J-6B centrifuge. The supernatant was centrifuged at 23000 r.p.m, in a Beckman SW25 rotor for 14 h and the resulting pellet was resuspended in I ml DNase I buffer with 0.1 mg/ml DNase I and incubated at 37 °C for 30 min. RNA was extracted with phenol at 65 °C, treated with RQI RNase-free DNase (Promega) and centrifuged at room temperature through 5.7 M-CsCI, 10 mM-EDTA pH 7.5 at 40000 r.p.m, for 14 h in a Beckman SW60 rotor. The RNA pellet was dissolved in 200 ~tl of water, precipitated with ethanol and stored in ethanol at -80 °C.
PCR. Ethanol-precipitated total nucleic acid (5 Ixl, approximately 0-570) or 10 ~tl CsCl-purified RNA was centrifuged through 500 ixi ethanol, dried, and used for reverse transcription (RT) and PCR. The usual 100 Itl RT-PCR mixture contained template, 10 mM-Tris-HC1 pH 8-4, 50 mM-KC1, 2.5 mM-MgCI2, 0-2 mM each dNTP, 50 pmol direct primer, 50 pmol reverse primer, 4 units (U) RNasin (Promega), 5 U avian myeloblastosis virus reverse transcriptase (Promega), 4 U AmpliTaq (Cetus) under 100 btl light mineral oil. The mixture was incubated for 1 h at 42 °C and then amplified by 35 cycles of PCR, each cycle consisting of l rain at 94 °C, 1.5 rain at 30 to 60 °C, depending on primers, and 1 to 5 min at 72 °C. The products of PCR were analysed on 1 70 agarose gels.
Antigen-capture PCR method. AGM-27 from the 107o liver homogenate was bound by monoclonal antibodies (MAbs) K2-4F2 or K3-4C8 (MacGregor et al., 1983 ) to 1.5 ml polypropylene microcentrifuge tubes and PCR with primers specific to the VP3 region was performed as described .
Cloning of PCR fragments. The PCR fragment consisting of nucleotides (nt) 3051 to 4417 ( Fig. 1 ) was digested with HindlII (at nt 3290) and BamHI (at nt 3813), and cloned between the HindlII and BamHI sites of pGEM-3Z (Promega). The PCR fragment consisting of nts 837 to 2248 was digested at internal sites with PstI (at nt 1006) and BgllI (at nt 1813), and cloned between the PstI and BamHI sites of pGEM-3Z. To clone the pCR fragment from the 5' end, an artificial EcoRI site was included at the 5' end of the direct primer 36-53 and an artificial BamHI site was included at the 5' end of reverse primer 309-326. The resultant PCR fragment was digested with EcoRI and BamHI, and cloned between the EcoRI and BamHI sites of pGEM-3Z.
Sequencing of PCR fragments and plasmids. PCR fragments were cut from 1 70 agarose gels and purified using Geneclean (Bio 101). Plasmids from minipreparations were extracted by the alkaline extraction method (Birnboim & Doly, 1979) and further purified using the Geneclean procedure. Double-stranded PCR fragments and plasmids were sequenced using Sequenase (United States Biochemical) as described (Winship, 1989) .
Computer analysis of sequences. Nucleotide sequences of various HAV strains were compared with that of AGM-27 using the global alignment program GAP from the GCG software package (Devereux et al., 1984) on a VAX 11/750 computer (Digital Equipment). Multiple alignments were made using the GCG program PRETTY to ensure that gaps in the sequence introduced by the GAP program were consistent between strains. Sequence identity was calculated as a percentage from the output of the GAP program using the shorter sequence length as the denominator in the GCG program DISTANCES.
Amino acid sequences were compared using the global alignment program SEQAP from the IDEAS software package (Goad et al., 1982) . Identity was calculated as a percentage from the output of the SEQAP program using the shorter sequence length as the denominator. Amino acid sequences representing the L protein (Forss et al., 1984; Palmenberg et al., t984) , or proteins VP4 to VP1 and 3B to 3D of AGM-27, HAV strain HM-175, encephalomyocarditis virus (Palmenberg et al., 1984) , poliovirus type 1 Mahoney (Kitamura et al., 1981 ; Racaniello et al., 1981) , foot-and-mouth disease virus type A 12 (Forss et al., 1984) , and rhinovirus type 2 (Skein et al., 1985) and type 14 (Stanway et al., 1984; Callahan et al., 1985) were compared using the program RELATE (Dayhoff, 1978) . 5"  VP4 VP2  VP3  VPI  2A 2B  i  II  I  I  I  I I  735 g04 1470  2208  3108 36753996   2C  3A 3B 3C  I II  I  5001 5292 Nucleotide numbering is based on the genomic map of HM-175 (Cohen et al., 1987a) . The sizes of PCR fragments shown (nucleotides) include the length of oligonucleotide primers.
74177
Virus growth in cell cultures. FRhK-4 and CV-1 cell monolayers were incubated with serial 10-fold dilutions of AGM-27 (10% liver homogenate) or a concentrated stock of cell culture-adapted HM-175. Diluted virus (0.15 ml) was added to monolayers of CV-1 or FRhK-4 cells, incubated for 90 min at 34.5 °C and then 1 ml ofDulbecco's MEM supplemented with 10% foetal calf serum was added. After a 20 day incubation in a CO2 incubator, 1 ml 2 x proteinase K buffer was added to each well to solubilize the cells; each well contained approximately the same number of cells as measured by light microscopy and determination of total DNA in cell lysates. RNA was isolated from an 80 I~1 sample by proteinase K digestion followed by phenol extraction, and then used for slot blot hybridization with 32p-labelled riboprobe corresponding to the negative strand of the entire HM-175 genome.
Results

Comparison of the AGM-27 genome sequence with those of other HA V genomes
The primary structure of the AGM-27 genome was determined from overlapping PCR fragments (Fig. 1) encompassing the genome between nts 36 and 7477 of HM-175 (Cohen et al., 1987a) . Direct sequencing of these fragments provided the AGM-27 sequence between nts 59 and 7458. In addition, some PCR fragments were subcloned into pGEM-3Z and sequences derived from portions of the individual clones were compared to the consensus sequence determined directly from PCR products.
Comparison showed that of five plasmids containing the region between nts 3290 and 3813 (genes 2A and 2B), two had sequences identical to that derived directly from the PCR product and the three other plasmids had six nucleotide substitutions, each of them leading to changes in the predicted amino acid sequence. One plasmid had four nucleotide substitutions at positions 3388 (A-,G; Glu-,Gly), 3653 (T-,C; Ser-,Pro), 3666 (A-,G; (Cohen et al., 1987a) , CR326 (Linemeyer et al., 1985) , HAS15 (Sverdlov et al., 1987) , LA (Najarian et al., 1985) and MBB (Paul et al., 1987) , of human origin, and PA21, of probable simian origin (Brown et al., 1989) .
t Compared using computer programs for global alignment (GAP) and multiple sequence alignment (DISTANCES) from the GCG Sequence Analysis Software Package (Devereux et al., 1984) .
Compared using a computer program for global alignment (SEQAP) from the IDEAS software package (Goad & Kanehisa, 1982) .
§ This is an approximate value. The sequence determined for AGM-27 starts from nucleotide 59 according to the nomenclature for HM-175 (Cohen et al., 1987a) . Between nucleotide 116 and 136 an ambiguous stretch of oligo(T) is present and, to make a continuous AGM-27 sequence for alignment, we assumed that there were 18 thymidines in this region.
Glu-,Gly) and 3750 (T-,A; Phe-,Tyr); one plasmid had a substitution at position 3663 (A-,G; Gln-,Arg) and another had a substitution at position 3719 (T~C; Ser-,Pro). Of the eight plasmids containing the region between nts 1006 and 1813 (VP3), six had sequences identical to that derived directly from PCR products. One plasmid had a nucleotide substitution at position 1712 (C ~ A), causing the replacement of Pro by Thr, and the other plasmid had a nucleotide substitution at position 1717 (T-C), which did not change the amino acid sequence. Comparison of the PCR-derived and plasmid-derived sequences of the 5' region is discussed below.
The primer for the extreme 3' end effective in PCR was complementary to the region just before the start of poly(A). The primer for the extreme 5' end effective in PCR corresponded to nts 36 to 53 of the HM-175 sequence. Five other primers corresponding to the region of HM-175 5' to nt 36 were not effective in PCR when used with the AGM-27 genome, although two of them were highly effective in PCR of the HM-175 genome. Therefore there may be extensive differences between AGM-27 and HM-175 in the 5' terminus of the genome.
Overall, the nucleotide and amino acid sequences of AGM-27 are less similar to those of human HAV strains than the human strains are to each other and are no more . Identity (%) between the HAV nucleotide sequences encoding capsid proteins, calculated using the programs GAP and DISTANCES (Devereux et al., 1984) . similar to those of HAV strain PA21, isolated from an owl monkey, than to other HAV strains (Table 1, Fig. 2) . Statistical analysis performed with the program RELATE (Dayhoff, 1978) indicated that the amino acid sequences of AGM-27 and HM-175 representing proteins VP4 to VPI and 3B to 3D have little similarity to the corresponding sequences of other picornaviruses; in these regions, AGM-27 did not appear to be more similar to any particular picornavirus than HM-175. 
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-change of the cleavage site from Gln-Val to Gln-Thr Of the amino acid changes noted, four in particular caused unique characteristics of the AGM-27 isolate. These important differences between AGM-27 and all other known human and simian HAVs are detailed in Fig. 3 . One of the four changes (Fig. 3b) leads to the replacement of Asp-70 with Ala-70 in VP3. This substitution is present in neutralization-resistant mutants of HM-175 which lack the ability to bind MAb K2-4F2, but can bind MAb K3-4C8 (Ping et al., 1988) . Using the antigen-capture PCR technique, we obtained specific PCR products when MAb K3-4C8 was used for the capture but not when K2-4F2 was used (data not shown). The other three critical changes are located in the translation initiation region (Fig. 3a) , in the VP1 region (Fig. 3c) and at the VP3-VP1 junction (Fig. 3d) . preliminary experiments we found that growth of AGM-27 could be detected by day 14 in either primary African green monkey kidney (AGMK) or FRhK-4 cells by immunofluorescence or slot blot hybridization assay. Therefore, virus replication was assayed by slot blot hybridization and autoradiography after 20 days (Fig. 4) . When FRhK-4 and CV-I cell lines were inoculated with 10-fold dilutions of 10% liver homogenates containing AGM-27, AGM-27 grew efficiently in FRhK-4 cells, even when diluted to |0 -4, but replication in CV-1 cells was not detected. In comparison, cell culture-adapted HM-175 grew relatively efficiently in both cell cultures; HM-175 growth was detected in both cell cultures when the inoculum was diluted 10 -6 and in neither cell culture when the inoculum was diluted 10 -7.
Growth of AGM-27 in cell culture
HAV is very difficult to grow in vitro and, normally, extended periods of adaptation are required before efficient growth in cell culture is achieved. However, in
Discussion
The PCR technique has been used recently for genomic analysis of different species (for review see Gelfand & White, 1990) . This technique has important advantages over molecular cloning procedures in that direct sequencing of PCR products provides the consensus sequence. This is important when one expects genome heterogeneity, as is the case of picornaviruses. The fidelity of Taq polymerase is high enough to obtain a reliable sequence by direct sequencing of PCR products (Fucharoen et al., 1989; Saiki et al., 1988; Tindal & Kunkel, 1988 ) but we also cloned PCR fragments. When the sequences obtained from direct PCR and cloned fragments were compared, no insertions or deletions were found in the 2A-2B, and VP3 gene regions. However, the frequency of nucleotide substitutions was different for these two regions: 0.26% in the 2A-2B region, and only 0.07% in VP3. In the present study it was not possible to determine whether the substitution frequencies obtained were due to heterogeneity of the virus population or to mistakes introduced by Taq polymerase or reverse transcriptase. However, among HAVs, the sequence of the VP3 region is more conserved than that of the 2A-2B region, which is consistent with the results obtained.
An oligopyrimidine tract within the 5' region of the AGM-27 genome was the only region difficult to sequence directly using the PCR product, but no difficulties in sequencing PCR products from the 5' region of the human strain, HM-175, were encountered. In contrast, the PCR product of AGM-27 was difficult to sequence because of heterogeneity in the number of thymidines in the oligo(T) tract. The exact number of residues in the tract is not known: from ten plasmids sequenced, one contained 11 thymidines, two had 12, two had 13, one had 12 and a cytosine after the fifth thymidine, one had 15 thymidines, one had 16, one had 17, one had 22 and another had one cytosine after the tenth thymidine. Although the possibility that some heterogeneity exists naturally in this region of the viral genome could not be ruled out, it was possible to demonstrate that Taq polymerase itself introduces heterogeneity in the number of thymidine residues during the PCR. We found that even when a cloned segment of this region containing 11 thymidines was used as the initial template for PCR, the products obtained were heterogeneous and again the number of thymidines could not be estimated accurately. Therefore, the number of thymidines identified in the oligo(T) tract at the 5' end of the AGM-27 sequence (Table 1) represents an estimate. For all other regions of the AGM-27 genome an unambiguous sequence was obtained by direct sequencing of PCR products.
The results of the sequence analyses suggest that simian-derived HAV strains AGM-27 and PA21 evolved separately from each other and human strains. Because the amino acid sequences of AGM-27 and HM-175 appear to be equally dissimilar to those of other picornaviruses, it appears that they evolved from an ancestral picornavirus at a similar time.
AGM-27 proved to be unique when compared to other known human and simian HAV isolates. Its uniqueness is seen deafly in a comparison of the total nucleotide or amino acid sequences (Table 1 and Fig. 2) , and most strikingly by major differences in the critical regions shown in Fig. 3 . The insertion of four nucleotides and several substitutions into the 5' non-coding region of AGM-27 (Fig. 3a) causes the major open reading frame to be extended by 12 nucleotides, so that VP4 of AGM-27 could be four amino acids longer than that of other HAVs. Of those four additional amino acids, three are methionines that might influence the initiation of translation.
Asp-70 of VP3 has been described as important for the formation of a major antigenic site (Ping et al., 1988) and for growth of human HAV strain HM-175 in vivo . Asp-70 is replaced by Ala in AGM-27 (Fig.  3b) , a result that was confirmed by sequencing eight cloned PCR fragments. Thus, the simian virus differs from the human virus in the apparent requirement for an Asp in this position for growth in vivo. However, this substitution did affect an antigenic site of AGM-27; neutralization-resistant mutants of the human strain containing Ala in position 70 of VP3 bind MAb K3-4C8, but not MAb K2-4F2 (Ping et al., 1988) . Similarly, when we used the antigen-capture PCR technique , AGM-27 did not appear to bind MAb K2-4F2, but was captured by MAb K3-4C8. Ser-102 of VP1, also described as important for creating an antigenic site (Ping et al., 1988) , was replaced by Ala in AGM-27 (Fig.  3c) . It has been shown that AGM-27 is antigenically distinct from human HAVs because it can be distinguished by MAb H7C27 (Karetnyi et al., 1989) . Finally, the cleavage site between VP3 and VP1, Gln-Val for all sequenced HAVs, is replaced by Gln-Thr in AGM-27 ( Fig. 3 d) ; the latter cleavage site has been identified only in foot-and-mouth disease virus among the picornaviruses. These variations in functionally important regions are not present in any other known human or simian strain of HAV and the data suggest that AGM-27 is a distinct new strain of HAV and possibly a true simian strain.
Comparison of the 3C and 3' non-coding regions of HAV strains AGM-27 and Cyno-55 revealed very high homology; only three nucleotide substitutions, none producing amino acid changes, were present in the 3C region. The cynomolgus and African green monkeys may have been infected by the same simian virus. Although the animals were originally from different regions [the cynomolgus monkey was from Indonesia (Andzhaparidze et al., 1985) and the African green monkey was from Kenya (Andzhaparidze et al., 1987) ], they were kept in the same vivarium and one or both probably was infected during captivity.
The fact that no haman HAV isolate has characteristics similar to those of AGM-27 could mean that this strain does not cause clinical hepatitis in humans and it may therefore be considered as a prospective candidate for a live vaccine against hepatitis A. On the other hand, its similarity to neutralization-resistant mutants of human strains (Ping et al., 1988) suggests that it may not cross-protect against wild-type human strains. Immunization-challenge experiments in primates to examine this possibility are now under way.
It has been demonstrated recently that attenuation of one isolate of virulent HAV occurred in parallel with its adaptation to growth in cell culture. Wild-type HAV isolated from clinical material grows extremely poorly in cell culture: in vitro replication usually cannot be detected in primate cells until 10 to 12 weeks after inoculation. Therefore it was totally unexpected to find that wild-type simian HAV grew efficiently in primary AGMK ceils and the FRhK-4 cell line without prior adaptation. The ability to grow directly in FRhK-4 or AGMK cells distinguished the clinical isolate of AGM-27 from those of wild-type HM-175. However, the inability of AGM-27 to grow in CV-1 cells distinguished it from the cell culture-adapted variant of HM-175.
These structural and biological data demonstrate that the AGM-27 strain differs significantly from any other known strain of HAV and thus may be a good model for further investigation of the molecular basis of HAV cellculture adaptation and attenuation. We are investigating these properties by constructing chimeras of simian and human strains.
